Masilamani Elizabeth Sobhia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Masilamani Elizabeth Sobhia has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
Harish Kumar
National Institute of Pharmaceutical Education and Research (NIPER)
8 shared publications- Matam Losery Stanly Paul
University of Szeged
7 shared publications Kapil Laddha
National Institute of Pharmaceutical Education and Research (NIPER)
6 shared publicationsKetan Ghosh
National Institute of Pharmaceutical Education and Research, S.A.S. Nagar
6 shared publicationsRajesh Singh
Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research (NIPER), Sector-67, S.A.S. Nagar (Mohali), Punjab, 160 062, India
6 shared publicationsSonia Kumari
Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and, Research (NIPER), Sector 67, S.A.S. Nagar (Mohali), Punjab, 166062, India
6 shared publications
Latest Publications
- Open Access
- 14 October 2026
- Published by Elsevier in South African Journal of Botany
- Vol. 199, 80-91
Antimycobacterial and antibiofilm studies on selected South African plants
- 14 October 2026
- Published by Elsevier in South African Journal of Botany
- Vol. 199, 80-91
Open AccessAntimycobacterial and antibiofilm studies on selected South African plants
- 3 April 2026
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 208, 111660
Beyond CRBN and VHL: Parkin driven lysine-based ternary complexes for selective β3-Tubulin degradation
- 3 April 2026
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 208, 111660
Beyond CRBN and VHL: Parkin driven lysine-based ternary complexes for selective β3-Tubulin degradation
- 4 March 2026
- Published by Taylor & Francis in Molecular Simulation
- Vol. 52 (5) , 381-397
Probing protein assemblies at the molecular level to understand force-induced conformational changes and interaction dynamics
1. Proteins are the fundamental building blocks of nature, enabling the formation of complex molecular machines and dynamic materials. Proteins, with their intricate three-dimensional structures an...
- 4 March 2026
- Published by Taylor & Francis in Molecular Simulation
- Vol. 52 (5) , 381-397
Probing protein assemblies at the molecular level to understand force-induced conformational changes and interaction dynamics
1. Proteins are the fundamental building blocks of nature, enabling the formation of complex molecular machines and dynamic materials. Proteins, with their intricate three-dimensional structures an...
- 23 February 2026
- Published by Taylor & Francis in Expert Opinion on Drug Discovery
- Vol. 21 (3) , 355-368
Computational insights and impact of combinatorial peptidomimetics on immune escape SARS-CoV-2 variants
1. Coronaviruses that belong to the Coronaviridae family have caused pandemic majorly in two waves across the world [1,2]. Based on pathogenicity and virulence on global public health, World Health...
- 23 February 2026
- Published by Taylor & Francis in Expert Opinion on Drug Discovery
- Vol. 21 (3) , 355-368
Computational insights and impact of combinatorial peptidomimetics on immune escape SARS-CoV-2 variants
1. Coronaviruses that belong to the Coronaviridae family have caused pandemic majorly in two waves across the world [1,2]. Based on pathogenicity and virulence on global public health, World Health...
- 23 January 2026
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry B
- Vol. 130 (5) , 1515-1529
Ternary Complex Geometry and Lysine Positioning Guide the Generation of PROTAC-Induced Degradable Complexes
Targeted protein degradation via PROTACs (PROteolysis TArgeting Chimaeras) has transformed drug discovery by enabling the elimination of disease-driving proteins, including those previously considered undruggable. However, rational PROTAC design remains hindered by the lack of systematic approaches to evaluate the geometry of ternary complexes, ubiquitination feasibility, and the influence of linker architecture on degradation potential. Here, we present an integrative computational framework that addresses these challenges by combining ternary complex generation, pairwise RMSD-based clustering, full CRL2VHL RING-like complex modeling, lysine proximity analysis, and structure-guided dynamics. As a representative system, we applied this workflow to PTP1B, a phosphatase implicated in oncogenic signaling yet long considered therapeutically challenging. Over 6900 ternary complex poses were generated across diverse linker designs and systematically filtered using custom Python scripts that automate pose clustering and lysine-to-E2 distance evaluation. Critical ternary complexes were subjected to molecular dynamics simulations, PCA, TICA, and Markov state modeling to reveal degradation-competent conformations and dynamic transitions. We additionally assessed AlphaFold-Multimer and Arg69-guided docking approaches. AlphaFold-Multimer produced few lysine-accessible poses, whereas Arg69-guided docking enriched degradation-competent geometries via biologically relevant interactions. This framework offers a mechanistically grounded and generalizable strategy for rational PROTAC development across protein targets.
- 23 January 2026
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry B
- Vol. 130 (5) , 1515-1529
Ternary Complex Geometry and Lysine Positioning Guide the Generation of PROTAC-Induced Degradable Complexes
Targeted protein degradation via PROTACs (PROteolysis TArgeting Chimaeras) has transformed drug discovery by enabling the elimination of disease-driving proteins, including those previously considered undruggable. However, rational PROTAC design remains hindered by the lack of systematic approaches to evaluate the geometry of ternary complexes, ubiquitination feasibility, and the influence of linker architecture on degradation potential. Here, we present an integrative computational framework that addresses these challenges by combining ternary complex generation, pairwise RMSD-based clustering, full CRL2VHL RING-like complex modeling, lysine proximity analysis, and structure-guided dynamics. As a representative system, we applied this workflow to PTP1B, a phosphatase implicated in oncogenic signaling yet long considered therapeutically challenging. Over 6900 ternary complex poses were generated across diverse linker designs and systematically filtered using custom Python scripts that automate pose clustering and lysine-to-E2 distance evaluation. Critical ternary complexes were subjected to molecular dynamics simulations, PCA, TICA, and Markov state modeling to reveal degradation-competent conformations and dynamic transitions. We additionally assessed AlphaFold-Multimer and Arg69-guided docking approaches. AlphaFold-Multimer produced few lysine-accessible poses, whereas Arg69-guided docking enriched degradation-competent geometries via biologically relevant interactions. This framework offers a mechanistically grounded and generalizable strategy for rational PROTAC development across protein targets.
- 4 September 2025
- Published by Springer Nature in In Silico Pharmacology
- Vol. 13 (3) , 1-22
Structure-guided design and triplicate molecular dynamics evaluation of mutant peptide inhibitors targeting SARS-CoV-2 main protease (Mpro)
The global health crisis caused by SARS-CoV-2 underscores the urgent need for effective antiviral therapeutics. The SARS-CoV-2 main protease (Mpro) is a crucial enzyme in viral replication, making it a prime target for drug development. In this study, we designed and evaluated peptide inhibitors targeting Mpro by introducing systematic mutations in the Nsp10/11 cleavage site peptide (QLMPER). A library of 214 mutant peptides was generated, from which 25 single-mutant and 70 multi-mutant peptides exhibited strong interactions with Mpro. The top four multi-mutant peptides were selected based on docking scores, molecular dynamics (MD) simulations, and MM–GBSA (Molecular Mechanics–Generalized Born Surface Area) binding free energy calculations. Triplicate 100 ns molecular dynamics simulations assessed the stability of these complexes, revealing that M3 exhibited the highest structural stability and lowest binding free energy (− 34 kcal/mol), outperforming the wild-type peptide (− 4.28 kcal/mol). Computational infrared (IR) spectral analysis confirmed structural modifications induced by mutations, while HOMO–LUMO analysis indicated enhanced reactivity for M3 (FLFPFR). These findings suggest that M3 (FLFPFR) is a promising candidate for SARS-CoV-2 inhibition, highlighting the potential of rationally designed peptide inhibitors in antiviral drug discovery. Graphical abstract Computational workflow for design and evaluation of mutant peptides against SARS-CoV-2 Mpro, highlighting the workflow, key interactions, and improved binding of mutants at S2 and S3/S4 subsites
- 4 September 2025
- Published by Springer Nature in In Silico Pharmacology
- Vol. 13 (3) , 1-22
Structure-guided design and triplicate molecular dynamics evaluation of mutant peptide inhibitors targeting SARS-CoV-2 main protease (Mpro)
The global health crisis caused by SARS-CoV-2 underscores the urgent need for effective antiviral therapeutics. The SARS-CoV-2 main protease (Mpro) is a crucial enzyme in viral replication, making it a prime target for drug development. In this study, we designed and evaluated peptide inhibitors targeting Mpro by introducing systematic mutations in the Nsp10/11 cleavage site peptide (QLMPER). A library of 214 mutant peptides was generated, from which 25 single-mutant and 70 multi-mutant peptides exhibited strong interactions with Mpro. The top four multi-mutant peptides were selected based on docking scores, molecular dynamics (MD) simulations, and MM–GBSA (Molecular Mechanics–Generalized Born Surface Area) binding free energy calculations. Triplicate 100 ns molecular dynamics simulations assessed the stability of these complexes, revealing that M3 exhibited the highest structural stability and lowest binding free energy (− 34 kcal/mol), outperforming the wild-type peptide (− 4.28 kcal/mol). Computational infrared (IR) spectral analysis confirmed structural modifications induced by mutations, while HOMO–LUMO analysis indicated enhanced reactivity for M3 (FLFPFR). These findings suggest that M3 (FLFPFR) is a promising candidate for SARS-CoV-2 inhibition, highlighting the potential of rationally designed peptide inhibitors in antiviral drug discovery. Graphical abstract Computational workflow for design and evaluation of mutant peptides against SARS-CoV-2 Mpro, highlighting the workflow, key interactions, and improved binding of mutants at S2 and S3/S4 subsites
- Open Access
- 10 April 2025
- Published by Open Exploration Publishing
- Vol. 3, 1008104
Revolutionizing diabetes treatment: computational insights into 4-hydroxy isoleucine derivatives and advanced molecular screening for antidiabetic compounds
Aim: This study aimed to computationally identify and optimize 4-hydroxy isoleucine (4HILe) derivatives from fenugreek as multitarget antidiabetic agents against α-glucosidase, α-amylase, and aldose reductase [PDB (protein data bank) IDs: 5NN8, 4GQR, 4QX4]. Methods: A multi-step computational workflow was employed to identify and optimize 4HILe derivatives as antidiabetic agents. Molecular docking using the Schrödinger Suite screened 23 ligands against three enzyme targets to evaluate binding affinities and interactions. Molecular dynamic (MD) simulations conducted with GROMACS (Groningen machine chemical simulations) over 100 ns assessed conformational stability through RMSD (root mean square deviation) and RMSF (root mean square fluctuation) analysis. Binding free energy calculations [MM-GBSA (molecular mechanics-generalized Born surface area)] and free energy landscape (FEL) studies are performed to validate the thermodynamics of protein-ligand interactions. Additionally, generative AI modeling using LigDream generated 100 novel compounds derived from 4HILe, subsequently validated through docking studies to identify promising inhibitors. Results: The study identified 4HILe-4, 2R-3S-4R-4HILe, and 4HILe-Amide-2 as potent derivatives with superior binding affinities [ΔG (Gibbs free energy): −49.3 to −42.3 kcal/mol] compared to co-crystal ligands (−45.3 kcal/mol), as determined by docking and MM-GBSA calculations. MD revealed stable protein-ligand complexes, evidenced by low RMSD values (0.2–0.4 nm) and minimal residue fluctuations (RMSF), confirming their structural integrity. The generative AI approach using LigDream also generated 100 novel 4HILe derivatives, with top candidates exhibiting strong docking scores and key molecular interactions against α-glucosidase, α-amylase, and aldose reductase. Notably, compound 10 (−9.424 kcal/mol), compound 4 (−8.167 kcal/mol), and compound 28 (−13.760 kcal/mol) emerged as promising inhibitors for further investigation. Conclusions: The study highlights 4HILe derivatives as promising inhibitors for diabetes-associated enzymes, demonstrating robust binding and dynamic stability. Integrating molecular dynamics, free energy calculations, and AI-driven generative modeling provides a strong framework for accelerating antidiabetic drug discovery. These findings pave the way for experimental validation and the development of next-generation therapeutics targeting insulin resistance and hyperglycemia.
- 10 April 2025
- Published by Open Exploration Publishing
- Vol. 3, 1008104
Open AccessRevolutionizing diabetes treatment: computational insights into 4-hydroxy isoleucine derivatives and advanced molecular screening for antidiabetic compounds
Aim: This study aimed to computationally identify and optimize 4-hydroxy isoleucine (4HILe) derivatives from fenugreek as multitarget antidiabetic agents against α-glucosidase, α-amylase, and aldose reductase [PDB (protein data bank) IDs: 5NN8, 4GQR, 4QX4]. Methods: A multi-step computational workflow was employed to identify and optimize 4HILe derivatives as antidiabetic agents. Molecular docking using the Schrödinger Suite screened 23 ligands against three enzyme targets to evaluate binding affinities and interactions. Molecular dynamic (MD) simulations conducted with GROMACS (Groningen machine chemical simulations) over 100 ns assessed conformational stability through RMSD (root mean square deviation) and RMSF (root mean square fluctuation) analysis. Binding free energy calculations [MM-GBSA (molecular mechanics-generalized Born surface area)] and free energy landscape (FEL) studies are performed to validate the thermodynamics of protein-ligand interactions. Additionally, generative AI modeling using LigDream generated 100 novel compounds derived from 4HILe, subsequently validated through docking studies to identify promising inhibitors. Results: The study identified 4HILe-4, 2R-3S-4R-4HILe, and 4HILe-Amide-2 as potent derivatives with superior binding affinities [ΔG (Gibbs free energy): −49.3 to −42.3 kcal/mol] compared to co-crystal ligands (−45.3 kcal/mol), as determined by docking and MM-GBSA calculations. MD revealed stable protein-ligand complexes, evidenced by low RMSD values (0.2–0.4 nm) and minimal residue fluctuations (RMSF), confirming their structural integrity. The generative AI approach using LigDream also generated 100 novel 4HILe derivatives, with top candidates exhibiting strong docking scores and key molecular interactions against α-glucosidase, α-amylase, and aldose reductase. Notably, compound 10 (−9.424 kcal/mol), compound 4 (−8.167 kcal/mol), and compound 28 (−13.760 kcal/mol) emerged as promising inhibitors for further investigation. Conclusions: The study highlights 4HILe derivatives as promising inhibitors for diabetes-associated enzymes, demonstrating robust binding and dynamic stability. Integrating molecular dynamics, free energy calculations, and AI-driven generative modeling provides a strong framework for accelerating antidiabetic drug discovery. These findings pave the way for experimental validation and the development of next-generation therapeutics targeting insulin resistance and hyperglycemia.
- 20 January 2025
- Published by Springer Nature in Molecular Diversity
- Vol. 29 (5) , 4341-4358
Optimizing antibody stability and efficacy in CD47- SIRPα inhibition via computational approaches
CD47, a cell surface protein, serves as a "don't eat me" signal that prevents immune cells from engulfing healthy cells upon its interaction with SIRPα. Cancer cells exploit this mechanism by overexpressing CD47 to evade immune destruction. Blocking the interaction between CD47 and its receptor, SIRPα, is a promising therapeutic strategy. Targeting the interactions between these surface proteins with small molecules is quite challenging, and on the other hand, antibodies offer potential. However, the interactions between antigen (CD47) and antibody (B6H12.2) play a crucial role in this scenario, and increasing the affinity by mutating the interacting residues might impact the inclination and effectiveness of the antibody towards antigen. Thus, this study focuses on designing antibodies with increased affinity and stability towards the antigen compared to the wild-type. Residual scanning calculations were performed to mutate the interacting as well as the hydrophobic residues of the antibody and affinity was assessed. Computational approaches, including antigen-antibody docking studies and molecular dynamics simulations, were employed to evaluate the affinity, stability and therapeutic potential of these modified antibodies.
- 20 January 2025
- Published by Springer Nature in Molecular Diversity
- Vol. 29 (5) , 4341-4358
Optimizing antibody stability and efficacy in CD47- SIRPα inhibition via computational approaches
CD47, a cell surface protein, serves as a "don't eat me" signal that prevents immune cells from engulfing healthy cells upon its interaction with SIRPα. Cancer cells exploit this mechanism by overexpressing CD47 to evade immune destruction. Blocking the interaction between CD47 and its receptor, SIRPα, is a promising therapeutic strategy. Targeting the interactions between these surface proteins with small molecules is quite challenging, and on the other hand, antibodies offer potential. However, the interactions between antigen (CD47) and antibody (B6H12.2) play a crucial role in this scenario, and increasing the affinity by mutating the interacting residues might impact the inclination and effectiveness of the antibody towards antigen. Thus, this study focuses on designing antibodies with increased affinity and stability towards the antigen compared to the wild-type. Residual scanning calculations were performed to mutate the interacting as well as the hydrophobic residues of the antibody and affinity was assessed. Computational approaches, including antigen-antibody docking studies and molecular dynamics simulations, were employed to evaluate the affinity, stability and therapeutic potential of these modified antibodies.
- Open Access
Indole-3 Carbinol and Diindolylmethane Mitigated β-Amyloid-Induced Neurotoxicity and Acetylcholinesterase Enzyme Activity: In Silico, In Vitro, and Network Pharmacology Study
Background: Alzheimer’s disease (AD) is a neurodegenerative disease characterized by beta-amyloid (Aβ) deposition and increased acetylcholinesterase (AchE) enzyme activities. Indole 3 carbinol (I3C) and diindolylmethane (DIM) are reported to have neuroprotective activities against various neurological diseases, including ischemic stroke, Parkinson’s disease, neonatal asphyxia, depression, stress, neuroinflammation, and excitotoxicity, except for AD. In the present study, we have investigated the anti-AD effects of I3C and DIM. Methods: Docking and molecular dynamic studies against AchE enzyme and network pharmacological studies were conducted for I3C and DIM. I3C and DIM’s neuroprotective effects against self and AchE-induced Aβ aggregation were investigated. The neuroprotective effects of I3C and DIM against Aβ-induced neurotoxicity were assessed in SH-S5Y5 cells by observing cell viability and ROS. Results: Docking studies against AchE enzyme with I3C and DIM show binding efficiency of −7.0 and −10.3, respectively, and molecular dynamics studies revealed a better interaction and stability between I3C and AchE and DIM and AchE. Network pharmacological studies indicated that I3C and DIM interacted with several proteins involved in the pathophysiology of AD. Further, I3C and DIM significantly inhibited the AchE (IC50: I3C (18.98 µM) and DIM (11.84 µM)) and self-induced Aβ aggregation. Both compounds enhanced the viability of SH-S5Y5 cells that are exposed to Aβ and reduced ROS. Further, I3C and DIM show equipotential neuroprotection when compared to donepezil. Conclusions: Our findings indicate that both I3C and DIM show anti-AD effects by inhibiting the Aβ induced neurotoxicity and AchE activities.
Open AccessIndole-3 Carbinol and Diindolylmethane Mitigated β-Amyloid-Induced Neurotoxicity and Acetylcholinesterase Enzyme Activity: In Silico, In Vitro, and Network Pharmacology Study
Background: Alzheimer’s disease (AD) is a neurodegenerative disease characterized by beta-amyloid (Aβ) deposition and increased acetylcholinesterase (AchE) enzyme activities. Indole 3 carbinol (I3C) and diindolylmethane (DIM) are reported to have neuroprotective activities against various neurological diseases, including ischemic stroke, Parkinson’s disease, neonatal asphyxia, depression, stress, neuroinflammation, and excitotoxicity, except for AD. In the present study, we have investigated the anti-AD effects of I3C and DIM. Methods: Docking and molecular dynamic studies against AchE enzyme and network pharmacological studies were conducted for I3C and DIM. I3C and DIM’s neuroprotective effects against self and AchE-induced Aβ aggregation were investigated. The neuroprotective effects of I3C and DIM against Aβ-induced neurotoxicity were assessed in SH-S5Y5 cells by observing cell viability and ROS. Results: Docking studies against AchE enzyme with I3C and DIM show binding efficiency of −7.0 and −10.3, respectively, and molecular dynamics studies revealed a better interaction and stability between I3C and AchE and DIM and AchE. Network pharmacological studies indicated that I3C and DIM interacted with several proteins involved in the pathophysiology of AD. Further, I3C and DIM significantly inhibited the AchE (IC50: I3C (18.98 µM) and DIM (11.84 µM)) and self-induced Aβ aggregation. Both compounds enhanced the viability of SH-S5Y5 cells that are exposed to Aβ and reduced ROS. Further, I3C and DIM show equipotential neuroprotection when compared to donepezil. Conclusions: Our findings indicate that both I3C and DIM show anti-AD effects by inhibiting the Aβ induced neurotoxicity and AchE activities.
- 29 July 2024
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 15 (8) , 1306-1318
Interplay of PROTAC Complex Dynamics for Undruggable Targets: Insights into Ternary Complex Behavior and Linker Design
Protein degraders, such as bifunctional proteolysis-targeting chimeras (PROTACs), selectively eliminate target proteins by leveraging the natural protein degradation machinery. PROTACs bridge the target protein with an E3 ligase, which induces ubiquitination and degradation. Investigating ternary complex structures elucidates the molecular mechanisms of their formation and degradation. This study examines the binding dynamics of E3 ligases (VHL, CRBN, and cIAP) with proteins of interest, focusing on dynamics, cooperativity, selectivity, linker length, and PROTAC conformations. The influence of interface residues and linker lengths on specific conformations for target proteins and E3 ligases is highlighted. Utilizing molecular dynamics and steered molecular dynamics simulations, the study provides comprehensive parameters on the behavior and stability of diverse ternary complexes. These insights are crucial for designing PROTACs targeting disease-causing proteins and advancing the development of degradable ternary complexes for therapeutic applications.
- 29 July 2024
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 15 (8) , 1306-1318
Interplay of PROTAC Complex Dynamics for Undruggable Targets: Insights into Ternary Complex Behavior and Linker Design
Protein degraders, such as bifunctional proteolysis-targeting chimeras (PROTACs), selectively eliminate target proteins by leveraging the natural protein degradation machinery. PROTACs bridge the target protein with an E3 ligase, which induces ubiquitination and degradation. Investigating ternary complex structures elucidates the molecular mechanisms of their formation and degradation. This study examines the binding dynamics of E3 ligases (VHL, CRBN, and cIAP) with proteins of interest, focusing on dynamics, cooperativity, selectivity, linker length, and PROTAC conformations. The influence of interface residues and linker lengths on specific conformations for target proteins and E3 ligases is highlighted. Utilizing molecular dynamics and steered molecular dynamics simulations, the study provides comprehensive parameters on the behavior and stability of diverse ternary complexes. These insights are crucial for designing PROTACs targeting disease-causing proteins and advancing the development of degradable ternary complexes for therapeutic applications.